Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Agilent Technologies Inc.

< Previous 1 2 3 4 5 6 Next >
Agilent Releases IVDR-Compliant Instruments, Kits, and Reagents for Use in the European Union
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Announces Collaboration with APC on Real-Time Process Monitoring
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Reports Second-Quarter Fiscal Year 2022 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Announces Cash Dividend of 21 Cents per Share
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Cervical Cancer
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent to Announce Second-Quarter Fiscal Year 2022 Financial Results May 24
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Joins the National Institute for Innovation in Manufacturing to Advance Biomanufacturing
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Highlights Genomics and Cell Analysis Solutions for Cancer Research at AACR 2022
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Muscle-Invasive Urothelial Carcinoma (MIUC)
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Esophageal Squamous Cell Carcinoma
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Joins AMBIC to Advance Biomanufacturing
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent to Participate at Cowen and Barclays Health Care Conferences
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent and University of Vermont Announce the Agilent Laboratory for Chemical Analysis (ALCA)
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Published Study Details Proof-of-Concept for COVID-19 Detection via Saliva Screening
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Reports First-Quarter Fiscal Year 2022 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Acquires Artificial Intelligence Technology to Enhance Lab Productivity
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Highlights Integrated Automation Solutions at SLAS 2022
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent and A*STAR’s SIFBI Sign Research Collaboration Agreement to Advance Singapore Agri-Food Industry
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Announces the Innovative Seahorse XF Pro Analyzer
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent to Webcast First-Quarter Fiscal Year 2022 Financial Results Presentation
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Presents Thought Leader Award to Professor Jason Kovacic
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Announces the Cary 3500 UV-Vis Spectrophotometer Compatibility with OpenLab
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent to Present at Evercore ISI Virtual Healthcare Conference
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Reports Fourth-Quarter and Fiscal Year 2021 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Announces New Ion Mobility LC/Q-TOF and Enhanced Solutions for Biotherapeutics at ASMS 2021
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Triple-Negative Breast Cancer (TNBC)
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent to Webcast Fourth-Quarter Fiscal Year 2021 Financial Results Presentation
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer
From Agilent Technologies Inc.
Via Business Wire
Tickers A
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback